Page last updated: 2024-12-07

7-(4'-amino)phenylthioandrostenedione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID125637
CHEMBL ID3245357
SCHEMBL ID1901028
MeSH IDM0091926

Synonyms (14)

Synonym
um 583
67340-72-1
(7r,8r,9s,10r,13s,14s)-7-(4-aminophenyl)sulfanyl-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-3,17-dione
chembl3245357 ,
bdbm50010070
SCHEMBL1901028
7alpha-apta
androst-4-ene-3,17-dione, 7-((4-aminophenyl)thio)-, (7alpha)-
um-583
7alpha-(4'-amino)phenylthio-4-androstene-3,17-dione
7alpha-(4'-amino)phenylthioandrostenedione
7-(4'-amino)phenylthioandrostenedione
7-[(4-aminophenyl)sulfanyl]androst-4-ene-3,17-dione
DTXSID50986603
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AromataseHomo sapiens (human)Ki0.01800.00000.60469.5010AID1132970; AID53885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AromataseHomo sapiens (human)Km0.06300.02000.13240.7600AID53903
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
negative regulation of chronic inflammatory responseAromataseHomo sapiens (human)
steroid biosynthetic processAromataseHomo sapiens (human)
estrogen biosynthetic processAromataseHomo sapiens (human)
androgen catabolic processAromataseHomo sapiens (human)
syncytium formationAromataseHomo sapiens (human)
negative regulation of macrophage chemotaxisAromataseHomo sapiens (human)
sterol metabolic processAromataseHomo sapiens (human)
female genitalia developmentAromataseHomo sapiens (human)
mammary gland developmentAromataseHomo sapiens (human)
uterus developmentAromataseHomo sapiens (human)
prostate gland growthAromataseHomo sapiens (human)
testosterone biosynthetic processAromataseHomo sapiens (human)
positive regulation of estradiol secretionAromataseHomo sapiens (human)
female gonad developmentAromataseHomo sapiens (human)
response to estradiolAromataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
iron ion bindingAromataseHomo sapiens (human)
steroid hydroxylase activityAromataseHomo sapiens (human)
electron transfer activityAromataseHomo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenAromataseHomo sapiens (human)
oxygen bindingAromataseHomo sapiens (human)
heme bindingAromataseHomo sapiens (human)
aromatase activityAromataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
endoplasmic reticulumAromataseHomo sapiens (human)
endoplasmic reticulum membraneAromataseHomo sapiens (human)
membraneAromataseHomo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID53715Inhibition of 0.25 uM [1-3H]-androst-4-ene-3,17-dione binding to Cytochrome P450 19A11984Journal of medicinal chemistry, Jun, Volume: 27, Issue:6
Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors.
AID1132971Competitive inhibition of human placental microsomal aromatase assessed as [C14]estrone/[C14]estradiol formation using [C14]androstenedione substrate by liquid scintillation counting1978Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
AID53903Apparent kinetic constant for binding to human placental Cytochrome P450 19A11995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
AID53733Inhibition of Cytochrome P450 19A1 at 0.25 uM1985Journal of medicinal chemistry, Jun, Volume: 28, Issue:6
7 alpha-substituted derivatives of androstenedione as inhibitors of estrogen biosynthesis.
AID53736Inhibition of human placental Cytochrome P450 19A1 at 250 nM1995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
AID1132969Inhibition of human placental microsomal aromatase assessed as inhibition of [C14]estrone/[C14]estradiol formation using 1.25 uM [C14]androstenedione substrate at 6.25 uM by liquid scintillation counting1978Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
AID230824Ratio of Km/Ki for human placental cytochrome P450 19A11995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
AID53734Inhibition of Cytochrome P450 19A1 at 1.25 uM1985Journal of medicinal chemistry, Jun, Volume: 28, Issue:6
7 alpha-substituted derivatives of androstenedione as inhibitors of estrogen biosynthesis.
AID1270825Inhibition of human aromatase extracted from placental microsomes using [1-3H]androstenedione as substrate at 1.25 uM2015European journal of medicinal chemistry, Nov-13, Volume: 105Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.
AID1132970Apparent inhibition of human placental microsomal aromatase assessed as [C14]estrone/[C14]estradiol formation using 0.075 to 0.515 uM [C14]androstenedione substrate by liquid scintillation counting1978Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
AID53737Inhibition of human placental Cytochrome P450 19A1 at 100 nM1995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
AID53716Inhibition of 1.25 uM [1-3H]-androst-4-ene-3,17-dione binding to Cytochrome P450 19A11984Journal of medicinal chemistry, Jun, Volume: 27, Issue:6
Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors.
AID1132968Inhibition of human placental microsomal aromatase assessed as inhibition of [C14]estrone/[C14]estradiol formation using 1.25 uM [C14]androstenedione substrate at 12.5 uM by liquid scintillation counting1978Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
AID53885Apparent binding affinity for human placental Cytochrome P450 19A11995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (53.85)18.7374
1990's4 (30.77)18.2507
2000's0 (0.00)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.65 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]